CRBN logo

Corbion Stock Price

Symbol: ENXTAM:CRBNMarket Cap: €954.2mCategory: Materials

CRBN Share Price Performance

€16.40
-4.80 (-22.64%)
48.6% undervalued intrinsic discount
€31.90
Fair Value
€16.40
-4.80 (-22.64%)
48.6% undervalued intrinsic discount
€31.90
Fair Value
Price €16.40
AnalystHighTarget €31.90
AnalystConsensusTarget €22.73
AnalystLowTarget €14.00

CRBN Community Narratives

AN
AnalystHighTarget
AnalystHighTarget·Updated
Fair Value €31.90 48.6% undervalued intrinsic discount

Rising Clean Label And PLA Demand Will Spur Bioplastics Adoption

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value €22.73 27.9% undervalued intrinsic discount

Thai Ramp-Up And Chinese Approvals Will Boost Efficiency

0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget·Updated
Fair Value €14.00 17.1% overvalued intrinsic discount

Rising Regulation And Costs Will Pressure Bioplastics With Fleeting Upsides

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent CRBN News & Updates

No updates

Corbion N.V. Key Details

€1.3b

Revenue

€958.2m

Cost of Revenue

€338.4m

Gross Profit

€272.8m

Other Expenses

€65.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
1.13
Gross Margin
26.10%
Net Profit Margin
5.06%
Debt/Equity Ratio
61.3%

Corbion N.V. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About CRBN

Founded
1919
Employees
2403
CEO
Olivier Rigaud
WebsiteView website
www.corbion.com

Corbion N.V. provides lactic acid and lactic acid derivatives, food preservation solutions, functional blends, and algae ingredients in the Netherlands, the United States, Asia, rest of North Americas, the rest of Europe, the Middle East, and Africa. It operates through Functional Ingredients & Solutions, and Health & Nutrition segments. The company offers acidification, color retention, decontamination, food safety and preservation, freshness and shelf life, health and nutrition, strengthening conditioning, and taste and texture food solutions; Purasorb R&D, a solution that offers a range of custom synthesis options; biochemical specialties solutions, such as solvency, antimicrobial, moisturization, and pharma; and algae ingredients solutions, including replacing fish oil and sustainable omega-3 sourcing. It also provides food antioxidants, fermentation and preservation ingredients, flavors, fortification, and lactic acid lactates and derivatives; chemical products, such as agrochemicals, safe solvents, polymer additives, and functional ingredients for other chemical industries; bioplastic products; pharma products; and personal care products, including skin acre, hair care, rinse-off, moisturization, skin lightening, anti-aging and personal care solutions, oral health, natural pH adjustment, emulsifiers and surfactants, and antimicrobial. In addition, the company offers Puralact B3, a resin formulator for coatings and adhesives; Purasolv, a solvent for supporting sustainable production of healthier and stronger crops; Purasolv BL, a green solution; and AlgaVia, culinary algae oils. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was incorporated in 1919 and is headquartered in Amsterdam, the Netherlands.

Dutch Market Performance

  • 7 Days: -0.8%
  • 3 Months: 0.2%
  • 1 Year: 0.6%
  • Year to Date: 2.2%
Over the last 7 days, the market has dropped 3.7%, driven by a decline of 5.8% in the Information Technology sector. Although the market performance has been flat over the past year. Earnings are forecast to grow by 8.7% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading